logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
07/05/2025
Sensei Biotherapeutics (SNSE.US): In the first quarter of 2025, the revenue was $0, unchanged from the previous quarter; earnings per share was -$0.27, improved from -$0.32 in the previous quarter.
Latest
2 m ago
U.S. stock market anomaly | Ford Motor Company (F.US) withdraws full-year performance guidance, opens lower and rises nearly 4%
2 m ago
Tesla's sales in Europe have dropped significantly, even as the new Model Y begins to gain traction.
2 m ago
In April, Tesla's sales in the main electric vehicle markets in Europe continued to decline, despite the launch of an upgraded version of their most popular model. The Society of Motor Manufacturers and Traders in the UK reported on Tuesday that the company registered only 512 new cars in the UK last month, a 62% decrease compared to the previous year. Tesla's sales in Denmark, the Netherlands, and Sweden saw even larger declines, with some markets dropping by two-thirds. Although Tesla has started delivering the updated Model Y SUV to customers, its sales in eight out of the top ten electric vehicle markets in Europe have still greatly decreased. The company's global assembly line adjustments earlier this year, including in Germany, resulted in a loss of several weeks of production, making its quarterly sales the worst since 2022.
4 m ago
Bank of China issues risk warning about staying away from illegal foreign exchange transactions.
6 m ago
Italy will sell 12-month bonds worth 8.5 billion euros on May 9th.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.